Chronic heart failure is a frequent disease that is associated with high mortality and limits the quality of patients’ life. Medication blocking the mineralocorticoid receptor are essential part of heart failure therapy but in many patients side effects prevent their use. In the present project we aim to understand the molecular mechanisms involved in the beneficial effect of mineralocorticoid receptor antagonists in cardiac cells and identify potential targets for cardio-selective pharmacological therapy.

Here you can get further information.